Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease

Thrombosis Research

Volumn 117, Issue 4, 2006, Pages 357-364

  Ünlü, Yahya ^a,b   Karapolat, Sami ^a   Karaca, Yaşar ^a   Kiziltunç, Ahmet ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Ankle brachial index; Atherosclerosis; Coagulation; Inflammation; Peripheral arterial disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; SERUM AMYLOID A;

ADULT; ARTERY DISEASE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEMOSTASIS; HUMAN; INFLAMMATION; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

ARTERITIS; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES;

EID: 32044442465     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.019     Document Type: Article

References (45)

1. C.T. Esmo Does inflammation contribute to thrombotic events Haemostasis 30 Suppl. 2 2000 34 40
2. M. Thor, A. Yu, and J. Swedenborg Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia Thromb Res 105 2002 379 383
3. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
4. E. Falk, and A. Fernandez-Oritz Role of thrombosis in atherosclerosis and its complications Am J Cardiol 75 1995 5B 11B
5. V. Fuster, J.T. Fallon, J.J. Badimon, and Y. Nemerson The unstable atherosclerotic plaque: clinical significance and therapeutic intervention Thromb Haemost 78 1997 247 255
6. A.L. Komarov, E.P. Panchenko, A.B. Dobrovolsky, YuA Karpov, A.D. Deev, and E.V. Titaeva D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease Eur Heart J 23 2002 1309 1316
7. M.P.M. De Matt, E.M. Bladbjerg, T. Drivsholm, K. Borch-Johnsen, L. Moller, and J. Jespersen Inflammation, thrombosis and atherosclerosis: results of the Glostrup study J Thromb Haemost 1 2003 950 957
8. K. Sasaki, Z. Ma, T.S. KhatlanI, M. Okuda, H. Inokuma, and T. Onishi Evaluation of feline serum amyloid A as an inflammatory marker J Vet Med Sci 65 4 2003 545 548
9. F.B. Smith, A.J. Lee, C.M. Hau, A. Rumley, G.D. Lowe, and F.G. Fowkes Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburg Artery Study Blood Coagul. Fibrinolysis 11 1 2000 43 50
10. A.K. Banerjee, J. Pearson, E.L. Gilliland, D. Gross, J.D. Lewis, and Y. Stirling A six-year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants Thromb Haemost 68 3 1992 261 263
11. R. Lassila, S. Peltonen, M. Lepantalo, O. Saarinen, P. Kauhanen, and V. Manninen Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin Arterioscler Thromb 13 12 1993 1738 1742
12. C. Cimminiello, and PAD Epidemiology and pathophysiology Thromb Res 106 2002 V295 V301
13. M.M. McDermott, P. Greenland, D. Green, J.M. Guralnik, M.H. Criqui, and K. Liu D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease Circulation 107 2003 3191 3198
14. A.J. Lee, F.G.R. Fowkes, G.D.O. Lowe, and A. Rumley Fibrin D-dimer, haemostatic factors and peripheral arterial disease Thromb Haemost 74 1995 828 832
15. M.M. McDermott, D. Green, P. Greenland, K. Liu, M.H. Criqui, and C. Chan Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index Am J Cardiol 92 2003 194 199
16. J.G. Van der Born, M.L. Bots, F. Haverkate, P. Meijer, A. Hofman, and C. Kluft Activation products of the haemostatic system in coronary, cerebrovascular, and peripheral arterial disease Thromb Haemost 85 2001 234 239
17. P.M. Ridker, C.H. Hennekens, A. Cerskus, and M.J. Stampfer Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men Circulation 90 1994 2236 2240
18. F.G.R. Fowkes, G.D.O. Love, E. Housley, A. Rattray, A. Rumley, and R.A. Elton Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease Lancet 342 1993 84 86
19. J.H. Jansson, B.O. Olofsson, and T.K. Nilsson Predicative value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease Circulation 88 1993 2030 2034
20. T.W. Meade, J.A. Cooper, Y. Stirling, D.J. Howarth, V. Ruddock, and G.J. Miller Factor VIII, ABO blood group and the incidence of ischaemic heart disease Br J Haematol 88 3 1994 601 607
21. M. Cortellaro, E. Cofrancesco, C. Boschetti, L. Mussoni, M.B. Donati, and M. Catalano Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group Thromb Haemost 72 2 1994 292 296
22. J.A. Dormandly, and R.B. Rutherford Management of Peripheral Arterial Disease (PAD). TASC Working Group Trans Atlantic Inter-Society Consensus (TASC) J Vasc Surg 31 1 pt 2 2000 S1 S296
23. R. Fontaine, M. Kim, and R. Kieny Die chirurgische behanlung der peripheren durchlutungsstorungen Helv Chir Acta 5/6 1954 499 533
24. S.A. Carter Response of ankle systolic pressure to leg exercise in mild or questionable arterial diseases N Engl J Med 287 1972 578 582
25. E.F. Bernstein, and A. Fronek Current status of non invasive tests in the diagnosis of peripheral arterial disease Surg Clin North Am 62 S3 1982 473 487
26. M.M. McDermott, M.H. Criqui, K. Liu, J.M. Guralnik, P. Greenland, and G.J. Martin The lower ABI calculated by averaging the dorsalis pedis and posterior tibial arterial disease J Vasc Surg 32 2000 1164 1171
27. W.R. Hiatt, S. Hoag, and R.F. Hamman Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley Diabetes Study Circulation 91 1995 1472 1479
28. Y. Ünlü, and B. Sönmez Influence of cardiovascular risk factors on the outcome of coronary artery bypass surgery Surg Today 33 7 2003 491 497
29. R. Kornowski, M.K. Hong, F.O. Tio, O. Bramwell, H. Wu, and M.B. Leon In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia J Am Coll Cardiol 31 1998 224 230
30. C. Yutani, H. Ishibashi-Ueda, T. Suzuki, and A. Kojima Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent stenosis Cardiology 92 1999 171 177
31. J.S. Yudkin, C.D. Stehouwer, J.J. Emeis, and S.W. Coppack C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction Arterioscler Thromb Vasc Biol 19 1999 972 978
32. I. Das Raised C-reactive protein levels in serum from smokers Clin Chim Acta 153 1985 9 13
33. B. Young, M. Gleeson, and A.W. Cripps C-reactive protein: a critical review Pathology 23 1991 118 124
34. I.M. van der Meer, M.P.M. de Maat, M.L. Bots, M.M.B. Breteler, J. Meijer, and A.J. Kiliaan Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis. The Rotterdam Study Arterioscler Thromb Vasc Biol 22 2002 838 842
35. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 14 1997 973 979
36. G. Liuzzo, L. Biasucci, J.R. Gallimore, R.L. Grillo, A.G. Rebuzzi, and M.B. Pepys The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N Engl J Med 331 1994 417 424
37. T. Katayama, H. Nakashima, T. Yonekura, T. Honda, Y. Suzuki, and S. Yano Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor J Cardiol 42 2 2003 49 56
38. C. Weiss, S. Regele, T. Velich, P. Bartsch, and T. Weiss Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1 Prostaglandins Leukot Essent Fat Acids 63 5 2000 271 277
39. J. Heinrich, H. Schulte, R. Schoenfeld, E. Kohler, and G. Assmann Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain Thromb Haemost 73 1995 374 379
40. M.A. Mendall, P. Patel, L. Ballam, D. Strachan, and T.C. Northfield C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study BMJ 312 1996 1061 1065
41. M. Schillinger, M. Exner, W. Mlekusch, H. Rumpold, R. Ahmadi, and S. Sabeti Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis Radiology 225 2002 21 26
42. M.W. Mosesson, K.R. Siebenlist, and D.A. Meh The structure and biological features of fibrinogen and fibrin Ann N Y Acad Sci 936 2001 11 30
43. J. Mandl, M. Csala, I. Lerant, G. Banhegyi, J. Biro, and R. Machovich Enhancement of interleukin-6 production by fibrinogen degradation product D in human peripheral monocytes and perfused murine liver Scand J Immunol 42 1995 175 178
44. T.J. Orchard, and D.E. Strandness Assessment of peripheral vascular disease in diabetes. American heart association scientific statement Circulation 88 1993 819 828
45. J.I. Weitz, J. Bryne, and G.P. Clagett Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review Circulation 94 1996 3026 3049